(Q44037150)

29 November 2017

1 reference

title

Autoimmune-like syndromes during TNF blockade: does infection have a role? (English)

1 reference

29 November 2017

0 references

Joerg C Prinz

1

1 reference

29 November 2017

language of work or name

English

0 references

publication date

29 March 2011

1 reference

Nature Reviews Rheumatology

29 November 2017

published in

1 reference

29 November 2017

volume

7

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

429-434

1 reference

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Autoimmune diseases induced by biological agents: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Autoimmune Diseases Induced by TNF-Targeted Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Drug-induced lupus due to anti-tumor necrosis factor alpha agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Tumor necrosis factor-alpha antagonists and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Neurological adverse events associated with anti-tumor necrosis factor α treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Management of herpes simplex virus type 1 pneumonia following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Viral causes of human myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Molecular mechanisms of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Autoantibodies in nonautoimmune individuals during infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Lupus-like presentation of parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Lyme neuroborreliosis: infection, immunity, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Borreliosis mimicking lupus-like syndrome during infliximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Human Cytomegalovirus Induces Systemic Immune Activation Characterized by a Type 1 Cytokine Signature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.35

Bell's palsy during etanercept treatment caused by neuroborreliosis

31 March 2020

1 reference

12 December 2020

Recombinant cytomegalovirus glycoprotein gB (UL55) induces an autoantibody response to the U1-70 kDa small nuclear ribonucleoprotein

1 reference

12 December 2020

Clearance of Apoptotic Cells in Human SLE

1 reference

12 December 2020

CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2011.35

1 reference

Dimensions Publication ID

29 November 2017

1040086014

0 references

1 reference